Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Elokdah Mahmoud Hassan
公开号:US20070037802A1
公开(公告)日:2007-02-15
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了一种式I化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。
SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:EP1931640A2
公开(公告)日:2008-06-18
US7723329B2
申请人:——
公开号:US7723329B2
公开(公告)日:2010-05-25
[EN] SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS<br/>[FR] DERIVES DE 3-SULFONYLINDAZOLE SUBSTITUES EN TANT QUE LIGANDS DE 5-HYDROXYTRYPTAMINE-6
申请人:WYETH CORP
公开号:WO2007021711A2
公开(公告)日:2007-02-22
[EN] The present invention provides a compound of formula (I) and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor. [FR] La présente invention concerne un composé représenté par la formule I, ainsi que l'utilisation dudit composé pour le traitement d'un trouble du système nerveux central associé à ou affecté par le récepteur 5-HT6.
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists
作者:Kevin G. Liu、Albert J. Robichaud、Alexander A. Greenfield、Jennifer R. Lo、Cristina Grosanu、James F. Mattes、Yanxuan Cai、Guo Ming Zhang、Jean Y. Zhang、Dianne M. Kowal、Deborah L. Smith、Li Di、Edward H. Kerns、Lee E. Schechter、Thomas A. Comery
DOI:10.1016/j.bmc.2010.10.033
日期:2011.1
develop agents for cognitive enhancement, we have been focused on the 5-HT6 receptor in order to identify potent and selective ligands for this purpose. Herein we report the identification of a novel series of 3-sulfonylindazole derivatives with acyclic amino side chains as potent and selective 5-HT6 antagonists. The synthesis and detailed SAR of this class of compounds are reported.